One of the Top Biotech Stocks to Buy Just Hit the Market
August 10, 2015 at 17:05 PM EDT
One of the last week's biggest IPOs, the food allergy company Aimmune Therapeutics Inc. (Nasdaq: AIMT), hit the market on Thursday, Aug. 6, and has already climbed more than 20%. AIMT's early success underscores one of the best biotech stocks to buy that Money Morning Executive Editor Bill Patalon has been recommending all year. Food allergies affect tens of millions around the world. And the companies that treat these people offer some of the best profit opportunities among biotech stocks today... Tags: Best Biotech Stocks , biotech stock , biotech stocks , biotech stocks 2015 , biotech stocks to buy , biotech stocks to buy now , Stocks to Buy , Stocks to Buy Now , top biotech stocks To get full access to all Money Morning content, click here About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free . Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors. Disclaimer: © 2015 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201. The post One of the Top Biotech Stocks to Buy Just Hit the Market appeared first on Money Morning - We Make Investing Profitable .